Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On dose distribution comparison.

Steve B Jiang1, Greg C Sharp, Toni Neicu

  • 1Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. jiang.steve@mgh.harvard.edu

Physics in Medicine and Biology
|February 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PRISM: An open-source framework for regularized material decomposition on a novel kV dual-layer imager.

Medical physics·2026
Same author

From models to agentic systems: the evolution of artificial intelligence in medical physics.

Physics in medicine and biology·2026
Same author

Technical Considerations on Proton Therapy in NRG's Multi-Institutional Clinical Trials.

International journal of radiation oncology, biology, physics·2026
Same author

Response to: "Smarter dose, or simply more dose? clarifying the clinical signal in ERI-guided Bayesian rectal radiotherapy".

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Corrigendum to "Clinical target volumes for glioma - Automated delineation to improve neuroanatomic consistency" [Phys. Imaging Radiat. Oncol. 36 (2025) 100865].

Physics and imaging in radiation oncology·2026
Same author

Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignancies.

Journal of the National Cancer Institute·2026

A new framework for comparing radiotherapy dose distributions is introduced. It uses maximum allowed dose difference (MADD) for accurate, clinically relevant comparisons in both dose and spatial domains, improving patient-specific quality assurance.

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiotherapy Quality Assurance

Background:

  • Quantitative comparison of radiation dose distributions is crucial in radiotherapy, particularly for intensity-modulated radiation therapy (IMRT).
  • Existing dose comparison methods have limitations and require improvements for clinical relevance, necessitating evaluation in both dose and spatial domains.

Purpose of the Study:

  • To develop a general framework for comparing dose distributions in radiotherapy.
  • To introduce a new concept, maximum allowed dose difference (MADD), for integrated dose and spatial domain comparison.
  • To propose a normalized dose difference (NDD) for practical clinical use.

Main Methods:

  • Developed a general framework for dose distribution comparison.
  • Introduced the concept of maximum allowed dose difference (MADD) to unify dose and spatial comparisons.

Related Experiment Videos

  • Derived formulae for MADD calculation for methods like composite analysis and gamma index.
  • Proposed normalized dose difference (NDD) for clinical convenience.

    • Main Results:

    • The MADD concept allows for comparisons entirely within the dose domain, encompassing both dose and spatial tolerances.
    • NDD is insensitive to dose gradient regions and accounts for both dose and spatial acceptance criteria via MADD.
    • The new method was successfully applied to test cases and a clinical example.

    Conclusions:

    • The proposed framework and NDD offer an accurate, simple, and clinically intuitive method for dose distribution comparison.
    • The approach is robust, insensitive to dose grid size, and easily implementable in existing software tools.
    • This advancement enhances patient-specific quality assurance in modern radiotherapy practices.